Healthequity Inc (HQY) VP Sells $524,305.00 in Stock

Healthequity Inc (NASDAQ:HQY) VP Darcy G. Mott sold 9,500 shares of the stock in a transaction that occurred on Tuesday, February 20th. The stock was sold at an average price of $55.19, for a total value of $524,305.00. Following the completion of the transaction, the vice president now directly owns 102,500 shares of the company’s stock, valued at $5,656,975. The sale was disclosed in a filing with the SEC, which is available at this link.

Healthequity Inc (NASDAQ:HQY) traded down $5.97 during mid-day trading on Thursday, reaching $50.74. The company had a trading volume of 1,270,000 shares, compared to its average volume of 562,308. Healthequity Inc has a 12-month low of $37.62 and a 12-month high of $57.72. The firm has a market cap of $3,080.00, a PE ratio of 68.57, a price-to-earnings-growth ratio of 2.13 and a beta of 1.70.

Healthequity (NASDAQ:HQY) last released its quarterly earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.13 by $0.04. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm had revenue of $56.80 million during the quarter, compared to analysts’ expectations of $55.27 million. During the same period last year, the firm posted $0.10 EPS. The business’s revenue was up 31.0% on a year-over-year basis. equities analysts expect that Healthequity Inc will post 0.73 earnings per share for the current year.

A number of brokerages have recently issued reports on HQY. BidaskClub raised Healthequity from a “hold” rating to a “buy” rating in a report on Friday, February 16th. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $57.00 target price for the company in a report on Saturday, February 10th. JPMorgan Chase & Co. dropped their target price on Healthequity from $52.00 to $51.00 and set an “overweight” rating for the company in a report on Wednesday, January 24th. Cantor Fitzgerald increased their target price on Healthequity from $56.00 to $60.00 and gave the stock an “overweight” rating in a report on Wednesday, February 7th. Finally, Robert W. Baird increased their target price on Healthequity from $48.00 to $49.00 and gave the stock a “neutral” rating in a report on Wednesday, February 7th. One investment analyst has rated the stock with a hold rating and ten have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and a consensus price target of $56.67.

A number of hedge funds have recently added to or reduced their stakes in the stock. Dimensional Fund Advisors LP boosted its position in Healthequity by 25.3% in the 2nd quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock valued at $23,591,000 after buying an additional 95,514 shares during the last quarter. State Street Corp boosted its position in Healthequity by 10.8% in the 2nd quarter. State Street Corp now owns 1,172,117 shares of the company’s stock valued at $58,411,000 after buying an additional 114,294 shares during the last quarter. Arrowstreet Capital Limited Partnership bought a new position in Healthequity in the 2nd quarter valued at $224,000. The Manufacturers Life Insurance Company boosted its position in Healthequity by 15.3% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 38,816 shares of the company’s stock valued at $1,935,000 after buying an additional 5,156 shares during the last quarter. Finally, California State Teachers Retirement System boosted its position in Healthequity by 3.9% in the 2nd quarter. California State Teachers Retirement System now owns 88,324 shares of the company’s stock valued at $4,401,000 after buying an additional 3,332 shares during the last quarter. 99.47% of the stock is owned by hedge funds and other institutional investors.

WARNING: This piece was posted by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another website, it was illegally copied and republished in violation of US & international copyright laws. The original version of this piece can be read at https://stocknewstimes.com/2018/02/22/healthequity-inc-hqy-vp-sells-524305-00-in-stock.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Insider Buying and Selling by Quarter for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply